Posted on September 7, 2016
Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in your healthcare management.
Last month, our webinar focused on working with your doctor to manage your side effects. Couldn’t make the webinar? Get our Top 5 Takeaways below and watch the replay. Read more
Posted on September 6, 2016
Last month, we debuted a survey asking you, our Colon Cancer Alliance friends and family, what you thought was worth investing in. Nearly 200 of you filled out the questions, telling us what you thought was important to you, and what you’d like to see us prioritize. Thank you to all of you who took the time to respond!
Here’s what you said. Read more
Posted on June 29, 2016
Release of More Current Clinical Trials Data Gives Patients Access to Better Information Faster
Today, we announced our breakthrough collaboration with online patient community Smart Patients on a free Clinical Trials Database and online community for patients with colorectal cancer. These tools use data from www.cancer.gov—made available today by the National Cancer Institute (NCI) as part of the Cancer Moonshot Summit hosted by Vice President Biden in Washington, DC. Smart Patients was selected by the NCI and the VP’s office to receive early access to this new data in order to provide feedback and incorporate the data into the Smart Patients online patient community.
Posted on June 16, 2016
The Colon Cancer Alliance applauds the final report from the U. S. Preventive Services Task Force (USPSTF) on screening for colorectal cancer.
First and foremost, the USPSTF has maintained its “A” grade to screening for colorectal cancer; recognizing the high level of certainty that screening reduces colorectal cancer mortality and recommending that adults between the ages of 50 and 75 get timely screening.
Secondly, the final report resolves the concerns we expressed regarding several items in the initial draft report, including labeling some screening methods as “recommended” and others as “alternative.”
We specifically named these tests in our concerns as a major barrier to screening for Americans, and we applaud the USPSTF for widening its inclusion for these newer and proven tests.
Posted on May 18, 2016
While the use of marijuana has been around for thousands of years, it has only become legal in 24 states and the District of Columbia within recent history. As more states continue to approve marijuana for medical purposes, it’s important to separate the myths from the facts surrounding this drug.
This blog is the third in this series. Read Part I and Part II.
Cannabis research policies vary across the world. For example, Canada and the Netherlands have government-run programs in which specialized companies supply quality-controlled herbal cannabis. The Czech Republic, Israel, Canada and the Netherlands have government-sponsored research programs.